Evidence map›Paper›PMID 36467638›Full record

ArticleFrontiers in veterinary science2022

Randomized placebo-controlled trial of feline-origin

Jody L Gookin, Sandra J Strong, José M Bruno-Bárcena, Stephen H Stauffer, Shelby Williams, Erica Wassack, M Andrea Azcarate-Peril, Marko Estrada, Alexis Seguin, Joerg Balzer and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in veterinary science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Feline-DerivedMicroorganisms · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Antioxidants (Basel, Switzerland) · 2024
    Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Jody L GookinDepartment of Clinical Sciences, College of Veterinary Medicine and Comparative Medicine Institute, North Carolina State University, Raleigh, NC, United States.
Sandra J StrongDepartment of Environmental Services, Wake County Animal Center, Raleigh, NC, United States.
José M Bruno-BárcenaDepartment of Plant and Microbial Biology, North Carolina State University, Raleigh, NC, United States.
Stephen H StaufferDepartment of Clinical Sciences, College of Veterinary Medicine and Comparative Medicine Institute, North Carolina State University, Raleigh, NC, United States.
Shelby WilliamsVeterinary Hospital Pharmacy, College of Veterinary Medicine and Comparative Medicine Institute, North Carolina State University, Raleigh, NC, United States.
Erica WassackVeterinary Hospital Pharmacy, College of Veterinary Medicine and Comparative Medicine Institute, North Carolina State University, Raleigh, NC, United States.
M Andrea Azcarate-PerilDivision of Gastroenterology and Hepatology, and UNC Microbiome Core, Department of Medicine, Center for Gastrointestinal Biology and Disease, School of Medicine, University of North Carolina, Chapel Hill, NC, United States.
Marko EstradaIDEXX Laboratories, Inc., West Sacramento, CA, United States.
Alexis SeguinIDEXX Laboratories, Inc., West Sacramento, CA, United States.
Joerg BalzerVet Med Labor GmbH Division, IDEXX Laboratories, Inc., Kornwestheim, Germany.
Gigi DavidsonVeterinary Hospital Pharmacy, College of Veterinary Medicine and Comparative Medicine Institute, North Carolina State University, Raleigh, NC, United States.
North Carolina State University · USIDEXX Laboratories (United States) · USIDEXX Laboratories (Germany) · DEMississippi State University · USUniversity of North Carolina at Chapel Hill · USWake County Human Services · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Diarrhea is the second most common cause of mortality in shelter kittens. Studies examining prevention strategies in this population are lacking. Probiotics are of particular interest but studies in cats are largely limited to healthy adults or those with induced disease. Only one study in domestic cats describes the use of host-derived bacteria as a probiotic. We previously identified Methods: We conducted a randomized, placebo-controlled, blinded clinical trial to determine the impact of a freeze-dried Results: One-hundred thirty kittens completed the study. Fifty-eight kittens received the probiotic and 72 received the placebo. There were no significant differences in age, weight upon initiation of the study, number of days in the study, average daily gain in body weight, or weight at completion of the study. Kittens treated with Discussion: Decreased incidence of diarrhea associated with preventative administration of

Indexed as

16S rRNA gene amplicon sequencingdiarrheal pathogensgrowth and survivalinfectionpolymerase chain reactionshelter medicine

Identifiers

PMID36467638
PMCPMC9714445
OpenAlexW4309604680

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.